UMeWorld Limited Announces Groundbreaking Study Published in the Journal of Lipid Research, Highlighting the Benefits of Low Triglyceride DAGola Cooking Oil for Athletes
UMeWorld (OTC: UMEWF) has announced the publication of a groundbreaking clinical study in the Journal of Lipid Research focusing on their DAGola cooking oil. The research investigated the effects of diacylglycerol (DAG) dietary intervention on hyperuricemia in athletes.
The study analyzed over 1,000 types of fats and metabolites in athletes' blood, revealing that DAGola oil consumption led to:
- Notable reduction in serum uric acid levels
- Lower triglycerides and healthier blood fat profiles
- Reduced oxidative stress
- Enhanced metabolic processing of waste products
- Sustained health benefits throughout the intervention period
The research validates DAGola's role in promoting metabolic health and athletic performance, potentially helping prevent conditions like gout, heart disease, and kidney problems that could compromise athletic performance.
UMeWorld (OTC: UMEWF) ha annunciato la pubblicazione di uno studio clinico innovativo nella rivista Journal of Lipid Research che si concentra sul loro olio da cucina DAGola. La ricerca ha esaminato gli effetti dell'intervento dietetico a base di diacilglicerolo (DAG) sull'iperuricemia negli atleti.
Lo studio ha analizzato oltre 1.000 tipi di grassi e metaboliti nel sangue degli atleti, rivelando che il consumo di olio DAGola ha portato a:
- Una notevole riduzione dei livelli di acido urico sierico
- Trigliceridi più bassi e profili di grasso nel sangue più sani
- Riduzione dello stress ossidativo
- Processamento metabolico migliorato dei prodotti di scarto
- Benefici per la salute sostenuti durante il periodo di intervento
La ricerca convalida il ruolo di DAGola nella promozione della salute metabolica e delle prestazioni atletiche, potenzialmente aiutando a prevenire condizioni come la gotta, le malattie cardiache e i problemi renali che potrebbero compromettere le prestazioni atletiche.
UMeWorld (OTC: UMEWF) ha anunciado la publicación de un estudio clínico innovador en el Journal of Lipid Research que se centra en su aceite de cocina DAGola. La investigación investigó los efectos de la intervención dietética de diacilglicerol (DAG) en la hiperuricemia en atletas.
El estudio analizó más de 1,000 tipos de grasas y metabolitos en la sangre de los atletas, revelando que el consumo de aceite DAGola condujo a:
- Una notable reducción en los niveles de ácido úrico sérico
- Bajos triglicéridos y perfiles de grasa en sangre más saludables
- Reducción del estrés oxidativo
- Mejor procesamiento metabólico de los productos de desecho
- Beneficios para la salud sostenidos a lo largo del periodo de intervención
La investigación valida el papel de DAGola en la promoción de la salud metabólica y el rendimiento atlético, ayudando potencialmente a prevenir condiciones como la gota, enfermedades cardíacas y problemas renales que podrían comprometer el rendimiento atlético.
UMeWorld (OTC: UMEWF)는 DAGola 요리 오일에 관한 획기적인 임상 연구가 Journal of Lipid Research에 발표되었다고 발표했습니다. 이 연구는 운동선수의 고요산혈증에 대한 다이아실글리세롤(DAG) 식이 개입의 효과를 조사했습니다.
이 연구는 운동선수의 혈액에서 1,000가지 이상의 지방과 대사산물을 분석하여 DAGola 오일 소비가 다음과 같은 결과를 초래했음을 밝혀냈습니다:
- 혈청 요산 수치의 현저한 감소
- 낮은 중성지방과 더 건강한 혈중 지방 프로필
- 산화 스트레스 감소
- 노폐물의 대사 처리 향상
- 개입 기간 동안 지속적인 건강 혜택
이 연구는 DAGola가 신진대사 건강과 운동 성능을 증진하는 역할을 검증하며, 운동 성능을 저해할 수 있는 통풍, 심장병 및 신장 문제와 같은 상태를 예방하는 데 도움이 될 수 있습니다.
UMeWorld (OTC: UMEWF) a annoncé la publication d'une étude clinique révolutionnaire dans le Journal of Lipid Research axée sur leur huile de cuisson DAGola. La recherche a étudié les effets de l'intervention diététique à base de diacylglycérol (DAG) sur l'hyperuricémie chez les athlètes.
L'étude a analysé plus de 1 000 types de graisses et de métabolites dans le sang des athlètes, révélant que la consommation d'huile DAGola a conduit à :
- Une réduction notable des niveaux d'acide urique sérique
- Des triglycérides plus bas et des profils de graisses sanguines plus sains
- Une réduction du stress oxydatif
- Un traitement métabolique amélioré des produits de déchet
- Des bénéfices pour la santé durables tout au long de la période d'intervention
La recherche valide le rôle de DAGola dans la promotion de la santé métabolique et de la performance athlétique, aidant potentiellement à prévenir des conditions telles que la goutte, les maladies cardiaques et les problèmes rénaux qui pourraient compromettre les performances athlétiques.
UMeWorld (OTC: UMEWF) hat die Veröffentlichung einer bahnbrechenden klinischen Studie im Journal of Lipid Research angekündigt, die sich auf ihr DAGola Speiseöl konzentriert. Die Forschung untersuchte die Auswirkungen der diacylglycerol (DAG) Ernährung auf Hyperurikämie bei Sportlern.
Die Studie analysierte über 1.000 Arten von Fetten und Metaboliten im Blut von Sportlern und zeigte, dass der Konsum von DAGola-Öl zu folgendem führte:
- Deutliche Reduktion der Serum-Harnsäurespiegel
- Geringere Triglyceride und gesündere Blutfettprofile
- Verminderter oxidativer Stress
- Verbesserte metabolische Verarbeitung von Abfallprodukten
- Nachhaltige Gesundheitsvorteile während des Interventionszeitraums
Die Forschung bestätigt die Rolle von DAGola bei der Förderung der metabolischen Gesundheit und der sportlichen Leistungsfähigkeit und könnte helfen, Zustände wie Gicht, Herzkrankheiten und Nierenprobleme zu verhindern, die die sportliche Leistung beeinträchtigen könnten.
- Publication in prestigious Journal of Lipid Research provides scientific validation for DAGola oil's health benefits
- Study demonstrates significant reduction in uric acid levels and improved blood lipid profiles in athletes
- Research shows sustained health benefits throughout the intervention period
- Product demonstrates potential for preventing multiple health conditions that could affect athletic performance
- Study indicates some athletes were 'non-responders' to the DAG diet, showing no changes in health markers
MIAMI, Feb. 18, 2025 (GLOBE NEWSWIRE) -- UMeWorld Limited (OTC: UMEWF) is pleased to announce the publication of a groundbreaking clinical study in the Journal of Lipid Research, titled “Lipidomics and Metabolomics Investigation into the Effect of DAG Dietary Intervention on Hyperuricemia in Athletes.” The study demonstrates the significant health benefits of DAGola-branded diacylglycerol (DAG) cooking oil, revealing its potential role in managing hyperuricemia (HUA) and reducing the risk of related health problems such as gout, diabetes, and cardiovascular disease.
This pioneering research is the first to explore the effects of a DAG-enriched diet specifically for athletes, who, despite being physically active, can still be prone to elevated uric acid levels, a condition that increases the risk of metabolic diseases. The study found that incorporating DAGola cooking oil into the athletes' diets led to a notable reduction in uric acid levels, suggesting its potential to not only improve performance but also support long-term health.
Key Findings from the Study:
- Comprehensive Lipidomics and Metabolomics Analysis: Researchers analyzed over 1,000 types of fats and metabolites in athletes' blood to determine the effects of the DAG diet. Results showed improved blood lipid profiles and metabolic health markers in those consuming DAGola oil.
- Significant Reduction in Uric Acid Levels: Athletes who responded positively to the DAG diet experienced a notable drop in serum uric acid levels, a key factor in preventing gout and other metabolic disorders. Non-responders showed no such changes, highlighting the personalized health benefits of DAGola oil.
- Healthier Blood Profiles: The DAG diet contributed to lower triglycerides, healthier fat levels in the blood, and reduced oxidative stress caused by free radicals, which are linked to muscle recovery and inflammation.
- Improved Waste Processing: Athletes on the DAG diet demonstrated enhanced metabolic processing of waste products like ammonia, which can otherwise lead to fatigue and decreased performance.
- Sustained Benefits Over Time: Reductions in serum triglycerides and uric acid levels remained significant throughout the intervention period, indicating that continued use of DAGola cooking oil may help maintain these health benefits.
Published in the highly respected Journal of Lipid Research, this study brings scientific rigor to the health claims surrounding DAGola cooking oil. Enriched with diacylglycerol (DAG), a lipid compound that metabolizes faster than traditional triglycerides, DAGola oil provides a healthier cooking option for athletes, offering quick energy without the metabolic stress associated with higher triglyceride oils.
DAG-based oil has been well-researched since 2000, with numerous clinical trials demonstrating its benefits in improving fat metabolism, reducing triglyceride levels, and supporting cardiovascular health. The findings from this latest study reinforce the existing body of research, further validating DAGola’s role in promoting metabolic health and athletic performance.
By reducing uric acid levels and improving blood fat profiles, DAGola oil could help prevent common conditions like gout, heart disease, and kidney problems - issues that could otherwise compromise performance and long-term health.
Michael Lee, CEO of UMeWorld Limited, said: "We are incredibly excited by the findings published in the Journal of Lipid Research, which provide valuable scientific validation of DAGola cooking oil’s health benefits for athletes. This research highlights the potential for DAGola oil to improve key health markers like uric acid and triglycerides, ultimately helping athletes achieve better performance and long-term wellness. Our team is proud to lead the way in producing products that support healthier lifestyles, and we’re thrilled to see the positive impact DAGola oil is having on athletes' health. As the study suggests, small dietary changes - like switching to DAGola cooking oil - can have a big impact on health. UMeWorld is excited to continue pioneering research that helps individuals live healthier, more active lives.”
About UMeWorld
At UMeWorld, we merge innovation with science to revolutionize the cooking oil industry. DAGola™ oil is a science-backed alternative with up to
About DAGola Inc.
DAGola Inc. is the U.S. branch of UMeWorld Limited. It focuses on selling innovative food products in North America. To learn more about DAGola Inc., visit www.dagolaoil.com and amazon.com/dagola
Forward-Looking Statements
This press release may contain forward-looking statements, about UMeWorld's expectations, beliefs or intentions regarding, among other things, its product development efforts, business, financial condition, results of operations, strategies or prospects. In addition, from time to time, UMeWorld or its representatives have made or may make forward-looking statements, orally or in writing. Forward-looking statements can be identified by the use of forward-looking words such as "believe," "expect," "intend," "plan," "may," "should" or "anticipate" or their negatives or other variations of these words or other comparable words or by the fact that these statements do not relate strictly to historical or current matters. These forward-looking statements may be included in, but are not limited to, various filings made by UMeWorld with the U.S. Securities and Exchange Commission, press releases or oral statements made by or with the approval of one of UMeWorld's authorized executive officers. Forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made. Because forward looking statements relate to matters that have not yet occurred, these statements are inherently subject to risks and uncertainties that could cause UMeWorld's actual results to differ materially from any future results expressed or implied by the forward-looking statements. Many factors could cause UMeWorld's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements, including, but not limited to, the factors summarized in UMeWorld's filings with the SEC. In addition, UMeWorld operates in an industry sector where securities values are highly volatile and may be influenced by economic and other factors beyond its control. UMeWorld does not undertake any obligation to publicly update these forward-looking statements, whether as a result of new information, future events or otherwise. Please see the risk factors associated with an investment in our securities which are included in our Annual Report on Form 20-F and other periodic and current reports filed with the Securities and Exchange Commission.
FAQ
What are the key findings of UMEWF's DAGola oil study published in February 2025?
How does DAGola cooking oil (UMEWF) differ from traditional cooking oils?
What health conditions can UMEWF's DAGola oil potentially prevent in athletes?
How long have the benefits of DAG-based oil been researched?
